2 insiders at PROCEPT BioRobotics Corporation (PRCT) reported open-market stock purchases totaling $10,981,258 in recent weeks, according to filings with the U.S. Securities and Exchange Commission. The largest reported purchase came from Desai Antal Rohit (director), who acquired 142,498 shares at $25.44 on March 05, 2026.
Source: SEC Form 4. Option grants and tax-withholding sales are excluded.
| Date | Insider | Role | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-08-07 | Wood Larry L | director, officer: President, CEO | 23,900 | $20.85 | $498,315 | SEC Form 4 |
| 2026-03-09 | Desai Antal Rohit | director | 1,300 | $25.42 | $33,042 | SEC Form 4 |
| 2026-03-09 | Desai Antal Rohit | director | 53,818 | $24.91 | $1,340,348 | SEC Form 4 |
| 2026-03-09 | Desai Antal Rohit | director | 43,581 | $24.08 | $1,049,500 | SEC Form 4 |
| 2026-03-06 | Desai Antal Rohit | director | 53,763 | $24.10 | $1,295,790 | SEC Form 4 |
| 2026-03-06 | Desai Antal Rohit | director | 106,554 | $23.33 | $2,485,713 | SEC Form 4 |
| 2026-03-05 | Desai Antal Rohit | director | 24,748 | $26.41 | $653,528 | SEC Form 4 |
| 2026-03-05 | Desai Antal Rohit | director | 142,498 | $25.44 | $3,625,021 | SEC Form 4 |
PROCEPT BioRobotics Corporation is a Healthcare company in the Medical - Devices industry. It carried a market capitalization of about $1.2B, with shares trading near $21.71.
This article is automated factual reporting of public SEC filings, for informational purposes only. It is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security, and reflects no opinion on the company. Figures are drawn from filings believed reliable but are not guaranteed. Always verify against the primary SEC filing and consult a licensed professional. Investing can lose value, up to total loss.